Replies to post #15703 on Mast Therapeutics, Inc. (MSTX)

[pray]

https://pitchbook.com/profiles/savara-pharmaceuticals-profile-investors-funding-valuation-and-analysis

Then look at
“Savara Pharmaceuticals Cap Table”

Under Series A 1,799,906 present shares @ $1.81 also notice this is only 11.45% of value.

If 11% is $1.81 I am assuming the other 79% would at least double the value hence $4.00.

Also note they have 11-50 full time employees were Mast only has 6 presently, and basically McCully gets paid as if he is an additional 6 ($300,000 yearly).

Hope this helps ....